title: Outcome of directly observed therapy for tuberculosis in Yokohama City, Japan.
abstract: BACKGROUND
  Yokohama City is currently developing directly observed treatment (DOT) in its programme, and requires guidance on types of DOT appropriate for local conditions.
  
  
  OBJECTIVE
  To assess the effectiveness of DOT for tuberculosis treatment in a retrospective study under operational conditions in Yokohama City.
  
  
  METHODS
  We included 80 patients with sputum-positive tuberculosis, 39 enrolled in DOT and 41 self-administered patients. The study was done at the National Hospital for Chest Diseases and the Community Clinic, which provide tuberculosis services with a standard daily short-course regimen. The main outcome measures were cure and treatment completion.
  
  
  RESULTS
  The cure or treatment completion rate for the DOT and self-administered groups were respectively 87.2% and 68.3%. In a multivariate logistic regression model, cure or treatment completion was significantly associated with out-patient DOT (OR 4.04, 95%CI 1.22-13.33, P = 0.022).
  
  
  CONCLUSIONS
  DOT was shown to be significantly superior to the self-administered regimen. However, our results were from an impoverished population with city-sponsored apartments and supplementary benefits. Further research will be needed to know the effectiveness of DOT in the general population.
authors.affiliation: Naka Health Centre of Yokohama City, Nihon-odori, Naka-ku, Yokohama City, Japan. ke00-tsuchida@city.yokohama.jp
authors.forename: K
authors.initials: K
authors.lastname: Tsuchida
authors.forename: H
authors.initials: H
authors.lastname: Koyanagi
mesh_terms: D000995:Antitubercular Agents / Q000008:administration & dosage*; D023801:Directly Observed Therapy / Q000379:methods*; D006801:Humans; D007564:Japan; D016015:Logistic Models; D008875:Middle Aged; D015999:Multivariate Analysis; D010349:Patient Compliance; D015397:Program Evaluation; D012189:Retrospective Studies; D012646:Self Administration; D016896:Treatment Outcome; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
chemical_list: D000995:Antitubercular Agents